Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Stem cell grafting in parkinsonism--why, how and when.

de Munter JP, Melamed E, Wolters ECh.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S150-3. doi: 10.1016/S1353-8020(13)70036-1. Review.

PMID:
24262169
2.

GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.

Wang F, Kameda M, Yasuhara T, Tajiri N, Kikuchi Y, Liang HB, Tayra JT, Shinko A, Wakamori T, Agari T, Date I.

Neurosci Res. 2011 Sep;71(1):92-8. doi: 10.1016/j.neures.2011.05.019. Epub 2011 Jun 15.

PMID:
21699926
3.

Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.

Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH.

Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7.

PMID:
21669041
4.

Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.

Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC.

J Neurosci Res. 2010 Sep;88(12):2669-81. doi: 10.1002/jnr.22435.

PMID:
20544825
5.

Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.

Gu S, Huang H, Bi J, Yao Y, Wen T.

Brain Res. 2009 Feb 27;1257:1-9. doi: 10.1016/j.brainres.2008.12.016. Epub 2008 Dec 16.

PMID:
19111525
6.
7.

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.

Ostenfeld T, Tai YT, Martin P, Déglon N, Aebischer P, Svendsen CN.

J Neurosci Res. 2002 Sep 15;69(6):955-65.

PMID:
12205689
8.

Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.

Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, Kordower J, Aebischer P, Svendsen CN.

Gene Ther. 2006 Mar;13(5):379-88.

PMID:
16355116
9.

Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.

Niles LP, Armstrong KJ, Rincón Castro LM, Dao CV, Sharma R, McMillan CR, Doering LC, Kirkham DL.

BMC Neurosci. 2004 Oct 28;5:41.

10.

Organotypic cultures as tools for optimizing central nervous system cell therapies.

Daviaud N, Garbayo E, Schiller PC, Perez-Pinzon M, Montero-Menei CN.

Exp Neurol. 2013 Oct;248:429-40. doi: 10.1016/j.expneurol.2013.07.012. Epub 2013 Jul 27. Review.

PMID:
23899655
11.

Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.

Chaturvedi RK, Shukla S, Seth K, Agrawal AK.

Exp Neurol. 2008 Apr;210(2):608-23. doi: 10.1016/j.expneurol.2007.12.016. Epub 2007 Dec 31.

PMID:
18272152
12.

Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

Collier TJ, Dung Ling Z, Carvey PM, Fletcher-Turner A, Yurek DM, Sladek JR Jr, Kordower JH.

Exp Neurol. 2005 Feb;191 Suppl 1:S60-7.

PMID:
15629762
13.

Advances in stem-cell--generated transplantation therapy for Parkinson's disease.

Sundberg M, Isacson O.

Expert Opin Biol Ther. 2014 Apr;14(4):437-53. doi: 10.1517/14712598.2014.876986. Review.

PMID:
24437368
14.

Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.

Ebert AD, Beres AJ, Barber AE, Svendsen CN.

Exp Neurol. 2008 Jan;209(1):213-23. Epub 2007 Oct 4.

PMID:
18061591
15.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
16.

Changes in cytokines and neurotrophins in Parkinson's disease.

Nagatsu T, Mogi M, Ichinose H, Togari A.

J Neural Transm Suppl. 2000;(60):277-90. Review.

PMID:
11205147
17.
18.
19.

Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.

Mine Y, Hayashi T, Yamada M, Okano H, Kawase T.

Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76. Erratum in: Neurosurgery. 2009 Dec;65(6):1062.

PMID:
19834380
20.

Differential effects of the trophic factors BDNF, NT-4, GDNF, and IGF-I on the isthmo-optic nucleus in chick embryos.

Janiga TA, Rind HB, von Bartheld CS.

J Neurobiol. 2000 Jun 5;43(3):289-303.

PMID:
10842241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk